Last reviewed · How we verify
Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent (Inspiron RL II)
Post-marketing, prospective, multicentric, non-randomized registry to evaluate the safety and efficacy of Inspiron Sirolimus Eluting Coronary Stent at the treatment of "real-world" patients.
Details
| Lead sponsor | Scitech Produtos Medicos SA |
|---|---|
| Status | COMPLETED |
| Enrolment | 2504 |
| Start date | Fri Jun 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Jan 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Coronary Artery Disease
Interventions
- implant
Countries
Brazil